Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
p53 Immunohistochemistry to Identify Very High-risk Primary Prostate Cancer: A Prospective Cohort Study with Three Decades of Follow-upEur Urol Oncol 2021 Dec 27;[EPub Ahead of Print], KH Stopsack, DC Salles, JB Vaselkiv, ST Grob, LA Mucci, TL Lotan
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.